Posts by: Charles Moore

Charles Moore

Charles Moore is a syndicated columnist for several major Canadian print newspapers and is the Contributing Science and Research editor for the website.

February 15, 2016February 15, 2016

Vermillion Names 7 Experts to Steering Committee for New Texas Pelvic Mass Registry

News

Vermillion, Inc., an Austin, Texas-based bio-analytical solutions company, announced the appointment of a seven-member Steering Committee for its new Pelvic Mass Registry to advance the early detection and treatment of gynecologic ... Read more

February 12, 2016February 12, 2016

Elagolix for Endometriosis Pain Gets Positive Reports from AbbVie in Early Results of Second Phase 3 Trial

News

Illinois-based AbbVie, in cooperation with Neurocrine Biosciences of San Diego, California, has announced positive top-line results from the second of two replicate Phase 3 clinical trials evaluating the efficacy and safety ... Read more

February 10, 2016February 10, 2016

Valirx Planning Endometriosis Clinical Test of Its Anti-Cell Growth Candidate, VAL201

News

Valirx plc, a London-based biopharmaceutical company specializing in oncology therapeutics and diagnostics with a particular focus on cancer treatments and associated biomarkers, is conducting a Phase 1/2 clinical trial of its ... Read more

February 5, 2016February 5, 2016

Clinical Trial for Endometriosis and Uterine Fibroid Treatment Now Enrolling Patients

News

North Chicago, Illinois-based AbbVie, in cooperation with Neurocrine Biosciences of San Diego, California, has announced the start of the first of two planned Phase 3 clinical studies to evaluate the safety and ... Read more

February 3, 2016February 3, 2016

Can Marijuana Relieve Menstrual (and Possibly Endometriosis) Pain?

News

Can medical marijuana provide relief to women suffering from pain associated with painful menstrual periods, and with endometriosis, a common gynecological disorder of unknown cause? FORIA, a startup based in ... Read more

January 18, 2016January 18, 2016

Repros Therapeutics Reports Positive Results In Proellex Clinical Trials Treating Endometriosis

News, Therapies

The Woodlands, Texas, based Repros Therapeutics Inc., a development stage biopharmaceutical company focused on the development of oral small molecule drugs for major unmet medical needs in male and female ... Read more

January 13, 2016January 13, 2016

Endometriosis Patients in US Gain Access to Norethindrone Acetate Tablets

News

Aurobindo Pharma Limited announced that the company has received final approval from the U.S. Food and Drug Administration (FDA) to manufacture and market norethindrone acetate tablets (5 mg) in the United ... Read more

December 21, 2015December 21, 2015

Women’s Excellence Brings NovaSure Endometrial Ablation To Southern Michigan

News

Women’s Excellence in Birmingham, Michigan has added NovaSure endometrial ablation to the range of gynecological services it offers. NovaSure provides a quick, safe, and simple procedure to lighten or stop women’s periods, ... Read more

December 2, 2015December 11, 2015

ObsEva and Kissei Pharmaceutical Collaborate To Develop and Commercialize Endometriosis Drug KLH-2109

News

Nagano, Japan based Kissei Pharmaceutical Co., Ltd. and ObsEva SA — headquartered in Geneva, Switzerland, have announced conclusion of an agreement granting exclusive rights to ObsEva to develop and commercialize ... Read more

November 30, 2015November 30, 2015

Clinical Study of Chronic Pelvic Pain Therapy Getting Underway

News

Endometriosis.org announced the commencement of the GaPP2 clinical trial in the U.K. to determine whether the anti-seizure drug gabapentin reduces pelvic pain in women for whom no disease cause has been ... Read more